NIU TECHNOLOGIES-SPONS ADR (NIU)

US65481N1000 - ADR

2.51  +0.15 (+6.36%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NIU. NIU was compared to 40 industry peers in the Automobiles industry. NIU has a bad profitability rating. Also its financial health evaluation is rather negative. NIU has a decent growth rate and is not valued too expensively.



2

1. Profitability

1.1 Basic Checks

NIU had negative earnings in the past year.
The reported net income has been mixed in the past 5 years: NIU reported negative net income in multiple years.
In multiple years NIU reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -12.41%, NIU perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
NIU has a Return On Equity of -24.85%. This is comparable to the rest of the industry: NIU outperforms 56.41% of its industry peers.
Industry RankSector Rank
ROA -12.41%
ROE -24.85%
ROIC N/A
ROA(3y)-1.71%
ROA(5y)3.32%
ROE(3y)-3.59%
ROE(5y)6.04%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 21.53%, NIU belongs to the top of the industry, outperforming 82.05% of the companies in the same industry.
In the last couple of years the Gross Margin of NIU has grown nicely.
The Profit Margin and Operating Margin are not available for NIU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y9.88%

3

2. Health

2.1 Basic Checks

NIU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NIU has been increased compared to 1 year ago.
The number of shares outstanding for NIU has been increased compared to 5 years ago.
Compared to 1 year ago, NIU has an improved debt to assets ratio.

2.2 Solvency

NIU has an Altman-Z score of 1.28. This is a bad value and indicates that NIU is not financially healthy and even has some risk of bankruptcy.
NIU has a better Altman-Z score (1.28) than 61.54% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that NIU is not too dependend on debt financing.
NIU has a Debt to Equity ratio of 0.24. This is in the better half of the industry: NIU outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACCN/A
WACC9.07%

2.3 Liquidity

NIU has a Current Ratio of 1.64. This is a normal value and indicates that NIU is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.64, NIU perfoms like the industry average, outperforming 58.97% of the companies in the same industry.
NIU has a Quick Ratio of 1.28. This is a normal value and indicates that NIU is financially healthy and should not expect problems in meeting its short term obligations.
NIU's Quick ratio of 1.28 is fine compared to the rest of the industry. NIU outperforms 64.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.28

4

3. Growth

3.1 Past

NIU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -442.69%.
The Revenue for NIU has decreased by -16.31% in the past year. This is quite bad
The Revenue has been growing by 12.40% on average over the past years. This is quite good.
EPS 1Y (TTM)-442.69%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-244.42%
Revenue 1Y (TTM)-16.31%
Revenue growth 3Y2.75%
Revenue growth 5Y12.4%
Revenue growth Q2Q-21.82%

3.2 Future

NIU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.32% yearly.
NIU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.15% yearly.
EPS Next Y141.64%
EPS Next 2Y62.15%
EPS Next 3Y39.32%
EPS Next 5YN/A
Revenue Next Year27.27%
Revenue Next 2Y21.02%
Revenue Next 3Y10.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NIU. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 12.69, NIU is valued correctly.
82.05% of the companies in the same industry are more expensive than NIU, based on the Price/Forward Earnings ratio.
NIU is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 12.69

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NIU's earnings are expected to grow with 39.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.15%
EPS Next 3Y39.32%

0

5. Dividend

5.1 Amount

No dividends for NIU!.
Industry RankSector Rank
Dividend Yield N/A

NIU TECHNOLOGIES-SPONS ADR

NASDAQ:NIU (5/9/2024, 11:22:42 AM)

2.51

+0.15 (+6.36%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap194.77M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.69
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.41%
ROE -24.85%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 21.53%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.64
Quick Ratio 1.28
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-442.69%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y141.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-16.31%
Revenue growth 3Y2.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y